Evaluation of Epstein-Barr Virus Latent Membrane Protein 2 Specific T-Cell Receptors Driven by T-Cell Specific Promoters Using Lentiviral Vector
Transduction of latent membrane protein 2 (LMP2)-specific T-cell receptors into activated T lymphocytes may provide a universal, MHC-restricted mean to treat EBV-associated tumors in adoptive immunotherapy. We compared TCR-specific promoters of distinct origin in lentiviral vectors, that is, Vβ6.7,...
Saved in:
| Main Authors: | Dongchang Yang, Qing Shao, Hua Sun, Xiaoxin Mu, Yun Gao, Runqiu Jiang, Jiajie Hou, Kun Yao, Yun Chen, Beicheng Sun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Clinical and Developmental Immunology |
| Online Access: | http://dx.doi.org/10.1155/2011/716926 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Silico Modeling and Characterization of Epstein–Barr Virus Latent Membrane Protein 1 Protein
by: Dayang-Sharyati D. A. Salam, et al.
Published: (2024-12-01) -
Autologous Epstein–Barr virus‐specific adoptive T‐cell therapy in a patient with lupus nephritis
by: Dwarakanathan Ranganathan, et al.
Published: (2024-01-01) -
Investigating Ultrafiltration Membranes and Operation Modes for Improved Lentiviral Vector Processing
by: Jennifer J. Labisch, et al.
Published: (2025-01-01) -
Epstein-Barr virus-encoded Latent Membrane protein-1(LMP-1) as a Prognostic marker in OSCC and OPMDs
by: Ramya Selvam, et al.
Published: (2024-03-01) -
Cell-specific delivery of CRISPR-Cas9 with pseudotyped lentiviral particles: Just change the envelope
by: Ángela Covo-Vergara, et al.
Published: (2024-12-01)